Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Korro Bio (KRRO) Cash from Operations (2019 - 2025)

Korro Bio (KRRO) has disclosed Cash from Operations for 6 consecutive years, with 17179000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Cash from Operations fell 6.74% year-over-year to 17179000.0, compared with a TTM value of 68354000.0 through Sep 2025, up 7.24%, and an annual FY2024 reading of 60074000.0, up 10.71% over the prior year.
  • Cash from Operations was 17179000.0 for Q3 2025 at Korro Bio, up from 19228000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 7495000.0 in Q4 2024 and bottomed at 25474000.0 in Q1 2021.
  • Average Cash from Operations over 5 years is 16732631.58, with a median of 17179000.0 recorded in 2025.
  • The sharpest move saw Cash from Operations tumbled 172.07% in 2021, then soared 64.49% in 2024.
  • Year by year, Cash from Operations stood at 17888000.0 in 2021, then skyrocketed by 38.36% to 11027000.0 in 2022, then crashed by 91.41% to 21107000.0 in 2023, then skyrocketed by 64.49% to 7495000.0 in 2024, then plummeted by 129.21% to 17179000.0 in 2025.
  • Business Quant data shows Cash from Operations for KRRO at 17179000.0 in Q3 2025, 19228000.0 in Q2 2025, and 24452000.0 in Q1 2025.